High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder (HDQ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00297947
Recruitment Status : Completed
First Posted : March 1, 2006
Last Update Posted : April 17, 2015
Nathan Kline Institute for Psychiatric Research
Information provided by (Responsible Party):
Jean-Pierre Lindenmayer, Manhattan Psychiatric Center